Sigma Healthcare (ASX:SIG) decided to withdraw its interest from and halt discussions regarding the acquisition of UK drugstore chain Boots Group, according to a Monday filing with the Australian bourse.
Following a preliminary review, the company concluded that the acquisition would not currently meet its strategic and capital investment objectives in advancing its UK expansion, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.